GGrantIndex
← Leaderboards

Gerald S. Supinski

Case Western Reserve University

$9,509,335
Attributed
$11,203,662
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$11,203,662 · 8
VA$0 · 1

By mechanism

R01$8,962,451 · 6
KL2$1,760,312 · 1
RC1$480,899 · 1
I01$0 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Muscle Strength

Research focus

Muscle StrengthMuscleCritical IllnessFunctional DisorderMuscle WeaknessMuscle FunctionCytokineRespiratory MusclesRespiratory FailureResearch StudySepsisAnimal ModelPreventMechanical VentilationGenerationsPathway InteractionsAnimalsInfectionInhibitor/AntagonistContractile ProteinsMediatingResponseCharacteristicsDiaphragm (Anatomy)

Grant awards (34)

Institutional Career Development Core$880,156
KL2 · FY2022 · TR
Institutional Career Development Core$880,156
KL2 · FY2021 · TR
Mitochondrially Targeted Therapies for Sepsis Induced Diaphragm Dysfunction$542,781
R01 · FY2020 · HL · contact PI
Mitochondrially Targeted Therapies for Sepsis Induced Diaphragm Dysfunction$542,781
R01 · FY2019 · HL · contact PI
Mitochondrially Targeted Therapies for Sepsis Induced Diaphragm Dysfunction$542,781
R01 · FY2018 · HL · contact PI
Respiratory Muscle Weakness$0
I01 · FY2018 · VA · contact PI
Respiratory Muscle Weakness$0
I01 · FY2017 · VA · contact PI
Treatment of Skeletal Muscle Dysfunction in ICU Patients$563,249
R01 · FY2016 · HL · contact PI
Respiratory Muscle Weakness$0
I01 · FY2016 · VA · contact PI
Treatment of Skeletal Muscle Dysfunction in ICU Patients$566,233
R01 · FY2015 · HL · contact PI
Respiratory Muscle Weakness$0
I01 · FY2015 · VA · contact PI
Treatment of Skeletal Muscle Dysfunction in ICU Patients$550,151
R01 · FY2014 · HL · contact PI
Treatment of Skeletal Muscle Dysfunction in ICU Patients$632,752
R01 · FY2013 · HL · contact PI
MAPK/PKR Modulation of Diaphragm Weakness$355,629
R01 · FY2010 · HL · contact PI
Evaluation and Treatment of Skeletal Muscle Weakness in Critically Ill Patients$480,899
RC1 · FY2009 · HL · contact PI
Caspase Mediated Diaphragmatic Dysfunction$355,629
R01 · FY2009 · HL · contact PI
MAPK/PKR Modulation of Diaphragm Weakness$355,629
R01 · FY2009 · HL · contact PI
Caspase Mediated Diaphragmatic Dysfunction$355,629
R01 · FY2008 · HL · contact PI
MAPK/PKR Modulation of Diaphragm Weakness$355,629
R01 · FY2008 · HL · contact PI
MAPK/PKR Modulation of Diaphragm Weakness$355,629
R01 · FY2007 · HL · contact PI
Caspase Mediated Diaphragmatic Dysfunction$355,629
R01 · FY2007 · HL · contact PI
Caspase Mediated Diaphragmatic Dysfunction$364,792
R01 · FY2006 · HL · contact PI
MAPK/PKR Modulation of Diaphragm Weakness$249,050
R01 · FY2006 · HL · contact PI
MAPK/PKR Modulation of Diaphragm Weakness$116,251
R01 · FY2006 · HL · contact PI
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$312,239
R01 · FY2005 · HL
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$305,171
R01 · FY2004 · HL
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$298,306
R01 · FY2002 · HL
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$33,261
R01 · FY2002 · HL
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$324,160
R01 · FY2001 · HL
DIAPHRAGMATIC DYSFUNCTION IN SEPSIS$79,321
R01 · FY2001 · HL
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$281,379
R01 · FY2000 · HL
DIAPHRAGMATIC DYSFUNCTION IN SEPSIS$127,240
R01 · FY2000 · HL
FREE RADICALS AND MUSCLE DYSFUNCTION IN HEART FAILURE$31,265
R01 · FY2000 · HL
DIAPHRAGMATIC DYSFUNCTION IN SEPSIS$9,885
R01 · FY2000 · HL